Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00639769 Head and Neck C...
cisplatin
irinotecan hydr...
18 Years - Vanderbilt-Ingram Cancer Center View Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00003809 Head and Neck C...
cetuximab
cisplatin
18 Years - 120 Years Eastern Cooperative Oncology Group View Biomarkers in Patients With Head and Neck Cancer NCT01466257 Head and Neck C...
cetuximab
cisplatin
DNA analysis
gene expression...
mutation analys...
laboratory biom...
18 Years - 120 Years Eastern Cooperative Oncology Group View Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors NCT00006036 Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 Years Canadian Cancer Trials Group View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer NCT00470496 Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Follicu...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Papilla...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Esthes...
Stage II Follic...
Stage II Invert...
Stage II Lympho...
Stage II Lympho...
Stage II Midlin...
Stage II Mucoep...
Stage II Papill...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
HPPH
photodynamic th...
conventional su...
18 Years - Roswell Park Cancer Institute View Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer NCT00040807 Head and Neck C...
docetaxel
irinotecan hydr...
18 Years - 120 Years Eastern Cooperative Oncology Group View Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy NCT00004865 Head and Neck C...
cetuximab
cisplatin
fluorouracil
paclitaxel
18 Years - National Cancer Institute (NCI) View Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors NCT00066651 Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI) View Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00006107 Head and Neck C...
Taxotere
Surgery
radiation thera...
18 Years - Dana-Farber Cancer Institute View Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer NCT00023959 Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI) View Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00020189 Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI) View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00096512 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer NCT00470496 Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Follicu...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Papilla...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Esthes...
Stage II Follic...
Stage II Invert...
Stage II Lympho...
Stage II Lympho...
Stage II Midlin...
Stage II Mucoep...
Stage II Papill...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
HPPH
photodynamic th...
conventional su...
18 Years - Roswell Park Cancer Institute View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer NCT00898664 Head and Neck C...
cytogenetic ana...
gene expression...
mutation analys...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Vanderbilt-Ingram Cancer Center View Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer NCT00004097 Head and Neck C...
fluorouracil
gemcitabine hyd...
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI) View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases NCT00062348 Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00113399 Head and Neck C...
filgrastim
cisplatin
docetaxel
fluorouracil
paclitaxel
radiation thera...
18 Years - Radiation Therapy Oncology Group View Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy NCT00004226 Head and Neck C...
radiation thera...
18 Years - National Cancer Institute (NCI) View Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck NCT02035527 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
cisplatin
docetaxel
Correlative Stu...
18 Years - Ohio State University Comprehensive Cancer Center View Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery NCT00041171 Adult Solid Tum...
Breast Cancer
Head and Neck C...
Kidney and Urin...
Male Reproducti...
Thorax and Resp...
Hypericum perfo...
docetaxel
placebo
18 Years - 120 Years Alliance for Clinical Trials in Oncology View Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer NCT00897793 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center View Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer NCT00281866 Head and Neck C...
erlotinib hydro...
18 Years - 120 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma NCT00004261 Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 Years University Health Network, Toronto View Docetaxel in Treating Patients With Solid Tumors NCT00003565 Bladder Cancer
Breast Cancer
Head and Neck C...
Lung Cancer
Unspecified Adu...
docetaxel
18 Years - Alliance for Clinical Trials in Oncology View Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00898742 Head and Neck C...
DNA and tissue ...
reverse transcr...
mass spectromet...
- Vanderbilt-Ingram Cancer Center View S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00337129 Head and Neck C...
eribulin mesyla...
18 Years - National Cancer Institute (NCI) View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT00896675 Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center View Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer NCT00899821 Head and Neck C...
aldesleukin
recombinant int...
sargramostim
immunologic tec...
biopsy
20 Years - 80 Years NYU Langone Health View BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors NCT00526149 Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00639769 Head and Neck C...
cisplatin
irinotecan hydr...
18 Years - Vanderbilt-Ingram Cancer Center View Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy NCT01156142 Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology View Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer NCT00006033 Head and Neck C...
gene therapy
interleukin-2 g...
methotrexate
18 Years - National Cancer Institute (NCI) View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy NCT00003856 Head and Neck C...
temoporfin
18 Years - National Cancer Institute (NCI) View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors NCT00006036 Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 Years Canadian Cancer Trials Group View Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab NCT00939627 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
cetuximab
placebo
sorafenib tosyl...
laboratory biom...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT00896675 Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center View Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck NCT00906360 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI) View Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer NCT00397384 Adenocarcinoma ...
Adenocarcinoma ...
Advanced Adult ...
Carcinoma of th...
Gastrointestina...
Metastatic Gast...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Unresectable Ex...
Unresectable Ga...
cetuximab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy NCT00559156 Head and Neck C...
arginine/omega-...
cisplatin
adjuvant therap...
radiation thera...
18 Years - National Cancer Institute (NCI) View Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer NCT00248560 Head and Neck C...
docetaxel
Gemcitabine
18 Years - 120 Years Barbara Ann Karmanos Cancer Institute View Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer NCT00509665 Head and Neck C...
doxorubicin hyd...
gemcitabine hyd...
18 Years - 120 Years Medical University of South Carolina View Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer NCT00448552 Head and Neck C...
capecitabine
oxaliplatin
18 Years - 120 Years University of Miami View Immunotoxin Therapy in Treating Patients With Advanced Cancer NCT00006981 Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI) View Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer NCT00573989 Head and Neck C...
erlotinib hydro...
pemetrexed diso...
quality-of-life...
intensity-modul...
18 Years - 120 Years Wake Forest University Health Sciences View Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer NCT00068497 Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI) View Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors NCT00019331 Colorectal Canc...
Endometrial Can...
Head and Neck C...
Liver Cancer
Lung Cancer
Melanoma (Skin)
Pancreatic Canc...
Testicular Germ...
Unspecified Adu...
aldesleukin
ras peptide can...
sargramostim
DetoxPC
18 Years - National Cancer Institute (NCI) View Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer NCT00616590 Fatigue
Head and Neck C...
Psychosocial Ef...
Sleep Disorders
medical chart r...
questionnaire a...
fatigue assessm...
quality-of-life...
21 Years - Vanderbilt University View Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer NCT00898300 Head and Neck C...
biologic sample...
biopsy
18 Years - Radiation Therapy Oncology Group View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors NCT00526149 Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer NCT00017511 Head and Neck C...
Oral Complicati...
Radiation Toxic...
cevimeline hydr...
18 Years - Daiichi Sankyo View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer NCT00022594 Head and Neck C...
liposomal lurto...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View Family Quality of Life Among Families With a Member Who is a Cancer Patient NCT00544336 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
Solid Tumor
questionnaire a...
survey administ...
quality-of-life...
21 Years - Vanderbilt-Ingram Cancer Center View Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer NCT00090337 Head and Neck C...
Pain
acupuncture the...
standard follow...
- Memorial Sloan Kettering Cancer Center View Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT00896675 Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center View Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer NCT00573989 Head and Neck C...
erlotinib hydro...
pemetrexed diso...
quality-of-life...
intensity-modul...
18 Years - 120 Years Wake Forest University Health Sciences View Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor NCT01096381 Breast Cancer
Cardiovascular ...
Colorectal Canc...
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Ovarian Cancer
Peritoneal Cavi...
Unspecified Adu...
laboratory biom...
questionnaire a...
18 Years - Vanderbilt-Ingram Cancer Center View Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor NCT01096381 Breast Cancer
Cardiovascular ...
Colorectal Canc...
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Ovarian Cancer
Peritoneal Cavi...
Unspecified Adu...
laboratory biom...
questionnaire a...
18 Years - Vanderbilt-Ingram Cancer Center View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00098631 Metastatic Squa...
Recurrent Metas...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Untreated Metas...
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer NCT00004070 Head and Neck C...
IL-12
18 Years - Dana-Farber Cancer Institute View Immunotoxin Therapy in Treating Patients With Advanced Cancer NCT00006981 Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI) View Vaccine Therapy in Treating Patients With Head and Neck Cancer NCT00404339 Head and Neck C...
mutant p53 pept...
tetanus toxoid ...
adjuvant therap...
18 Years - 120 Years University of Pittsburgh View Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck NCT00033618 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
ixabepilone
laboratory biom...
18 Years - National Cancer Institute (NCI) View Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection NCT01249443 HIV Infection
Recurrent Anal ...
Recurrent Breas...
Recurrent Esoph...
Recurrent Gastr...
Recurrent Metas...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Anal C...
Stage IV Breast...
Stage IV Esopha...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
vorinostat
diagnostic labo...
pharmacological...
carboplatin
paclitaxel
18 Years - AIDS Malignancy Consortium View Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00006471 Head and Neck C...
Fenretinide
18 Years - M.D. Anderson Cancer Center View Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer NCT00008398 Head and Neck C...
Oral Complicati...
Radiation Toxic...
sargramostim
quality-of-life...
radiation thera...
- Radiation Therapy Oncology Group View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy NCT01806675 Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Male Breast Can...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Colon...
Recurrent Esthe...
Recurrent Hypop...
Recurrent Inver...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Nasop...
Recurrent Non-s...
Recurrent Oroph...
Recurrent Pancr...
Recurrent Paran...
Recurrent Recta...
Recurrent Renal...
Recurrent Saliv...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Saliv...
Stage IVB Colon...
Stage IVB Saliv...
Stage IVC Saliv...
Tongue Cancer
Unspecified Adu...
18F-fludeoxyglu...
18F-FPPRGD2
18 Years - Stanford University View